<prompt> Omalizumab True statement is-Anti-IgEUsed as add on therapy in moderate to severe asthma prophylaxisGivn subcutaneouslyAll o above  <response>: Ans. is d i.e. All of above Anti-IgE Omalizumab.o Omalizumab is a humanized monoclonal antibody that binds IgE, thereby presenting its binding to the high- affinity IgE receptor and blocking IgE-mediated allergic responses and inflammation,o approved for patients 12 yr old with moderate to severe asthma,o It is given even 2-4 wk subcutaneously based on body weight and serum IgE levels.o Its clinical efficacy- as an add-on therapy for patients with moderate to severe allergic asthma It is generally well tolerated, although local injection site reactions can occur. 